We are live on ! Find out more
AC

Argentiere Capital Portfolio holdings

AUM $15.4M
1-Year Est. Return 8.82%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
-8.82%
3 Year Est. Return
+1.98%
5 Year Est. Return
+9.17%
10 Year Est. Return
–
AUM
$298M
AUM Growth
+$49.3M
Cap. Flow
-$48.6M
Cap. Flow %
-16.3%
Top 10 Hldgs %
85.7%
Holding
79
New
14
Increased
10
Reduced
11
Closed
38

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$38M
2
AGN
Allergan plc
AGN
+$33.6M
3
NXPI icon
NXP Semiconductors
NXPI
+$31.1M
4
TWX
Time Warner Inc
TWX
+$21.3M
5
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$14.5M

Top Sells

Rank Stock Value
1
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$19M
2
EZA icon
iShares MSCI South Africa ETF
EZA
+$14.7M
3
RAI
Reynolds American Inc
RAI
+$13.1M
4
HAL icon
Halliburton
HAL
+$5.98M
5
EPI icon
WisdomTree India Earnings Fund ETF
EPI
+$5.07M

Sector Composition

Rank Sector Weight
1 Healthcare 20.85%
2 Technology 17.15%
3 Communication Services 14.47%
4 Materials 10.31%
5 Financials 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEM icon
1
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$47.2M 15.83%
1,141,290
+933,990
+451% +$38M
NXPI icon
2
NXP Semiconductors
NXPI
$57.8B
$43.8M 14.67%
400,000
+290,000
+264% +$31.1M
TWX
3
DELISTED
Time Warner Inc
TWX
$43.2M 14.47%
430,000
+215,000
+100% +$21.3M
AGN
4
DELISTED
Allergan plc
AGN
$37.9M 12.7%
155,927
+143,170
+1,122% +$33.6M
MON
5
DELISTED
Monsanto Co
MON
$30.8M 10.31%
260,000
+90,000
+53% +$10.5M
EWZ icon
6
iShares MSCI Brazil ETF
EWZ
$9.28B
$14.5M 4.86%
425,068
+403,130
+1,838% +$14.5M
BCR
7
DELISTED
CR Bard Inc.
BCR
$14M 4.69%
+44,300
New +$13.2M
UTHR icon
8
United Therapeutics
UTHR
$25.8B
$10.1M 3.39%
77,957
-1,410
-2% -$176K
WFM
9
DELISTED
Whole Foods Market Inc
WFM
$8.42M 2.82%
+200,000
New +$7.28M
JPM icon
10
JPMorgan Chase
JPM
$935B
$5.8M 1.95%
63,500
-20,000
-24% -$1.73M
INCY icon
11
Incyte
INCY
$24.2B
$4.03M 1.35%
32,000
+17,000
+113% +$2.16M
BMRN icon
12
BioMarin Pharmaceuticals
BMRN
$11.6B
$3.9M 1.31%
43,000
+2,000
+5% +$182K
SHPG
13
DELISTED
Shire pic
SHPG
$3.31M 1.11%
+20,000
New +$3.5M
INTC icon
14
Intel
INTC
$455B
$3.28M 1.1%
97,130
+15,884
+20% +$568K
GS icon
15
Goldman Sachs
GS
$300B
$3M 1%
13,500
– –
CPAY icon
16
Corpay
CPAY
$25B
$2.8M 0.94%
19,400
– –
EWZ icon
17
PUT
iShares MSCI Brazil ETF
EWZ
$9.28B
$2.4M 0.8%
1,600,000
-887,000
-36% -$31.9M
C icon
18
Citigroup
C
$222B
$1.99M 0.67%
29,800
-30,000
-50% -$1.84M
BAC icon
19
Bank of America
BAC
$435B
$1.97M 0.66%
81,100
– –
COST icon
20
Costco
COST
$422B
$1.89M 0.63%
11,795
-3,880
-25% -$669K
MS icon
21
Morgan Stanley
MS
$331B
$1.81M 0.61%
40,732
– –
SGEN
22
DELISTED
Seagen Inc. Common Stock
SGEN
$1.55M 0.52%
+30,000
New +$1.91M
GILD icon
23
Gilead Sciences
GILD
$162B
$1.42M 0.47%
20,000
-35,000
-64% -$2.33M
WDC icon
24
Western Digital
WDC
$188B
$1.33M 0.45%
19,845
– –
EEM icon
25
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$1.32M 0.44%
1,756,900
-1,243,100
-41% -$50.6M
1
2 3 4

Similar funds

TCM
TVR Capital Management Stamford, Connecticut $16.3M AUM 45.87% 1-Year Est. Return
HCA
Hillview Capital Advisors Wayne, Pennsylvania $18.8M AUM 1.7% 1-Year Est. Return
DPA
Delphi Private Advisors San Diego, California $19.6M AUM 1.25% 1-Year Est. Return
MP
Manifold Partners San Francisco, California $10.4M AUM 5.49% 1-Year Est. Return
MMPI
Morgenthaler Management Partners IX Portola Valley, California $22.6M AUM
AF
Aristotle Fund Portland, Maine $6.27M AUM 17.13% 1-Year Est. Return
KAM
Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return
BA
Belvedere Advisors San Francisco, California $3.24M AUM

Argentiere Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Argentiere Capital held 79 positions worth $298M, up 20% from $249M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Argentiere Capital withdrew a net $48.6M in Q2 2017, closing 38 positions and reducing 11 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 11% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Argentiere Capital opened a new position in CR Bard Inc. worth $14M.

  • Argentiere Capital's largest Q2 2017 buy was CR Bard Inc.: 44,300 shares worth $14M.
  • Argentiere Capital added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $38M increase.
  • Argentiere Capital's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $2.33M.
  • Argentiere Capital fully exited State Street Financial Select Sector SPDR ETF in Q2 2017, selling an estimated $19M.
  • Argentiere Capital's ten largest holdings make up 86% of its $298M portfolio in Q2 2017.
  • Argentiere Capital opened 14 new positions and closed 38 in Q2 2017.
  • Argentiere Capital's portfolio value rose 20% quarter-over-quarter to $298M.

Based on Argentiere Capital's 13F filing for Q2 2017, filed 14 Aug 2017.